Health Care Select Sector SPDR (XLV)

Add to Watchlists
Create an Alert
69.18 +0.42  +0.61% NYSE Arca Nov 26, 8:00PM BATS Real time Currency in USD
View Full Chart
XLV Price Chart

XLV Description

Health Care Select Sector SPDR is a long only equity fund managed by SPDR State Street Global Advisors that tracks the S&P Health Care Select Sector TR USD index and has 12.54B USD assets under management. It has an expected distribution yield of 1.28%, a Forecasted PE Ratio of 21.44, and a Forecasted Price to Book Value of 3.627. The fund has a net expense ratio of 0.16%, turns over its positions 5.43% per year, and is traded on the New York Stock Exchange Arca.

XLV Key Info

Expense Ratio (1-31-14) 0.16%
Assets Under Management (11-26-14) 12.54B
30-Day Average Volume (11-26-14) 9.521M
Net Asset Value (11-26-14) 69.18
Discount or Premium to NAV (11-26-14) 0.00%
Turnover Ratio (9-30-13) 5.43%

XLV Asset Allocation

Type % Net % Long % Short
Cash 0.12% 0.12% 0.00%
Stock 99.88% 99.88% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Nov. 25, 2014

XLV Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00%
Greater Europe 0.00%
United Kingdom 0.00%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Nov. 24, 2014
Region breakdown data is calculated by using the long position holdings of the portfolio.

XLV Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 99.27%
Industrials 0.00%
Real Estate 0.00%
Technology 0.73%
Utilities 0.00%
As of Nov. 25, 2014

XLV Stock Market Capitalization

Giant 56.15%
Large 38.37%
Medium 5.37%
Small 0.00%
Micro 0.00%
As of Nov. 25, 2014
View More Holdings

XLV Top 10 Holdings

Name % Weight Price Chg %
Johnson & Johnson 11.48% 107.21 +0.48%
Pfizer Inc 7.37% 31.10 +2.07%
Merck & Co Inc 6.53% 59.75 +0.69%
Gilead Sciences Inc 5.83% 100.30 -0.80%
Amgen Inc 4.70% 164.72 +1.53%
AbbVie Inc 4.13% 68.70 +0.94%
Bristol-Myers Squibb Company 3.72% 58.86 +0.58%
UnitedHealth Group Inc 3.66% 98.11 +0.21%
Celgene Corp 3.39% 112.61 +1.39%
Actavis PLC 2.88% 270.47 +0.06%
As of Nov. 25, 2014
Get Quote for
Advertisement

XLV Basic Info

Style
Asset Class Sector Equity
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Health Care Select Sector TR USD 100.0%
Key Dates
Inception Date 12/16/1998
Last Annual Report Date 9/30/2013
Last Prospectus Date 1/31/2014
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available RRSP No

XLV Manager Info

Name Tenure
John Tucker 14.76 yrs
Michael Feehily 3.75 yrs

XLV Risk Info

Beta 0.7107
30 Day Average Volatility 13.79%

XLV Fundamentals

Dividend Yield TTM (11-26-14) 1.28%
Weighted Average PE Ratio 25.36
Weighted Average Price to Sales Ratio 1.955
Weighted Average Price to Book Ratio 4.100
Weighted Median ROE 21.11%
Weighted Median ROA 9.16%
Forecasted Dividend Yield 1.48%
Forecasted PE Ratio 21.44
Forecasted Price to Sales Ratio 1.917
Forecasted Price to Book Ratio 3.627
Number of Holdings 55.00
As of Nov. 25, 2014

XLV Growth Estimates

Forecasted 5 Yr Earnings Growth 9.63%
Forecasted Book Value Growth 9.03%
Forecasted Cash Flow Growth 1.33%
Forecasted Earnings Growth 5.50%
Forecasted Revenue Growth 7.81%
As of Nov. 25, 2014

XLV Performance

  Returns Total Returns
1M 6.09% 6.09%
3M 8.60% 8.99%
6M 17.23% 18.09%
1Y 25.08% 26.95%
3Y 118.2% 130.3%
5Y 122.4% 144.2%
As of Nov. 26, 2014

XLV Flows

1M 118.57M
3M 1.324B
6M 810.74M
YTD 1.358B
1Y 1.625B
3Y 2.847B
5Y 4.613B
As of Oct. 31, 2014
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.